European Patent Office received nearly 200 000 patent applications last year, with 10.1% coming from China; China ranks 4th globally in European patent applications; Huawei is No.
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the China National Intellectual Property Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback